Skip to main content
TipRanks
Go Ultimate75% OFF

Nektar Therapeutics (NKTR) Q2 2026 Earnings Report

1 Followers

CH:NKTR Q2 2026 EPS Results

Actual EPS
-CHF 1.03
Consensus EPS
-CHF 1.65
Beat/Miss
Beat by +CHF 0.62
One Year Ago EPS
-CHF 2.46

CH:NKTR Q2 2026 Revenue Results

Actual Revenue
CHF 8.46M
Expected Revenue
CHF 8.71M
Beat/Miss
Missed by -CHF 245.58K
YoY Revenue Growth
-9.34%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/13/2026
Time
After Close
Conference Call
Thursday, August 13, 2026
CH:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

CH:NKTR Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:NKTR Earnings History

CH:NKTR earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-2.08--1.49――
Nov 12, 20262026 (Q3)-1.73-1.36-1.5612.83% (+0.20)
Aug 13, 20262026 (Q2)-1.65-1.03-2.4658.31% (+1.44)
May 07, 20262026 (Q1)-1.32-1.52-3.0149.44% (+1.49)
Mar 12, 20262025 (Q4)-2.07-1.490.38-495.56% (-1.86)
Nov 06, 20252025 (Q3)-2.24-1.56-2.2630.74% (+0.69)
Aug 07, 20252025 (Q2)-2.53-2.46-3.1321.33% (+0.67)
May 08, 20252025 (Q1)-2.14-3.01-2.38-26.32% (-0.63)
Mar 12, 20252024 (Q4)-1.700.38-2.76113.64% (+3.13)
Nov 07, 20242024 (Q3)-2.49-2.26-3.0125.00% (+0.75)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed